SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that Dr. Alexandre Abizaid, co-principal investigator for REVA’s RESTORE II clinical trial, is presenting information on the Company’s bioresorbable scaffold program at the Cardiovascular Research Technologies (CRT) 2014 conference at 1:55 p.m. US EST on Monday, February 24, 2014. The conference is being held February 22nd through 25th at the Omni Shoreham Hotel in Washington, DC.
Help employers find you! Check out all the jobs and post your resume.
